  Vaccinations against the virus SARS-CoV-2 have proven to be most effective
against a severe corona disease. However, a significant minority of people is
still critical of such a vaccination or even strictly reject it. One but surely
not the only reason for this is the fear of undesired adverse effects. During
the year 2021 in Germany alone approximately 150 million vaccination doses have
been applied. This should be a solid basis to assess the risk of adverse
effects of corona vaccinations. Based on publicly available data, especially
from the German Federal Institute of Vaccines and Biomedicines
(Paul-Ehrlich-Institut) and further scientific publications from Europe, Israel
and the United States, this paper tries to give sound quantitative statements
on the risk of (severe) adverse effects (e.g. myocarditis, thrombosis and
thrombocytopenia, venous thrombosis, including cerebral venous sinus thrombosis
and fatalities based thereon) of the various vaccination types, i.e. Comirnaty,
Vaxzevria, Janssen and the Spikevax Covid-19 vaccine. The paper also describes
some quite serious concerns about the lack of details in the publicly available
data and the variations in the structure of reports from the primary source
that prohibit even simple time series comparisons. However, from an overarching
view all provided vaccines are pretty safe and fall mostly into the same
frequency categories with respect to various clusters of undesired
complications. Nevertheless there are statistically significant differences
amongst the four vaccines which indicate that Vaxzevria is according to some
important aspects only the second best preferable choice.
  The paper aims to support a rational approach regarding the confidence in the
widely available SARS-CoV-2 vaccines through a purely statistical investigation
of the number of adverse effects in an unbiased manner.
